The largest database of trusted experimental protocols

Syndrome

Syndrome refers to a set of signs and symptoms that collectively characterize a particular health condition or disease.
Syndromes can involve a wide range of bodily systems and functions, and may be caused by genetic, environmental, or other factors.
Understanding syndromes is crucial for accurate diagnosis, effective treatment, and advancing medical research.
PubCompare.ai's AI-driven protocol comparisons can help identify the best methodologies from literature, pre-prints, and patents to enhance reproducibility and accuracy in syndrome research, simplifying the research process and achieving more reliablee results.

Most cited protocols related to «Syndrome»

An international Consensus Committee, consisting of investigators with years of experience in dystonia (AA, KB, MD, SF, HAJ, CK, AEL, JKT), was set up to review the literature on dystonia and provide a consensus on classification of dystonia as well as on terminology of dystonic disorders.
The preparatory work of the group consisted of the collection and review of pertinent publications on the definition and classification of dystonia syndromes. Computerized MEDLINE searches including publications from 1966 to January 2012 were conducted using a combination of text words and MeSH terms: “dystonia”, “dystonic disorders”, “dystonia musculorum deformans”, “Meige syndrome”, “torticollis”, and “classification” limited to human studies. The reference lists of all known primary articles were searched for additional, relevant citations. No language restrictions were applied. A first draft of the manuscript was prepared based on the results of the literature review, data analysis, discussion and comments from the Committee members. To reach the consensus, the draft and the preliminary conclusions were critically discussed by a first consensus group during two conferences held in May and October 2011. The final document was subject to review by five neurologists experienced in the field of dystonia, who had not attended the initial consensus (SBB, MH, JJ, JWM, VF). The resulting criticism was evaluated by the Committee and a final consensus including the complete panel was convened in 2012.
The meetings utilized the consensus development conference methodology to arrive at the current criteria for definition and classification 22 . Accordingly, the consensus process involves the following principles: all members (1) contribute to the discussion, (2) can state each issue in their own words, (3) have the opportunity and time to express their opinion about each issue, and (4) agree to take responsibility for the implementation of a decision. Members who do not share the majority opinion will agree to support the group decision initially on a trial basis, pending further discussion. Achieving consensus requires that all members (1) listen non-judgmentally to the opinions of other members and (2) check for understanding by summarizing what they think they hear while building on each other’s thoughts and exploring minority opinions.
Publication 2013
ARID1A protein, human Auditory Perception Committee Members Conferences Dystonia Disorders Dystonia Musculorum Deformans Hearing Homo sapiens Meige Syndrome Minority Groups Neurologists Syndrome Thinking Torticollis
The present work forms part of an ongoing multi-year project to develop an ICVD, which uses a structured process for developing international consensus definitions for vestibular symptoms, syndromes, disorders, and diseases. This process, overseen by the Classification Committee of the Bárány Society (CCBS), is based on expert, multi-disciplinary committees with international representation developing diagnostic criteria for subsequent comment and refinement prior to publication. These criteria are built on a critical appraisal of current best scientific evidence. All definitions are supported by notes, comments, and written discussion according to a template established by the CCBS for ICVD. The criteria for BVP were developed iteratively over a three-year period (2014–2017) through discussion, presentation, and refinement. Special care was taken to ensure that the criteria are specific and practical and can be applied in every country all over the world. This is particularly true for the use of certain laboratory examinations not available everywhere.
Publication 2017
Diagnosis Physical Examination Syndrome Vestibular Labyrinth
General psychological symptoms were assessed using the Symptom Checklist-90-Revised [21 ] at baseline, and its abbreviated version, the Brief Symptom Inventory (BSI) [22 ], at follow-up. Both versions are based on identical items and have been shown to present fairly equivalent psychometric properties [23 (link), 24 (link)]. Hence, we focused our analyses on the BSI. The BSI is a widely used 53-item measure of subjective psychological distress experienced in the preceding seven days. All responses are scored on a 5-point scale from 0 (“not at all”) to 4 (“extremely”). The BSI’s nine subscales cover symptoms of clinically relevant psychological syndromes: somatization, obsessive-compulsive disorder, interpersonal sensitivity, depression, anxiety, phobic anxiety, paranoid ideation, and psychoticism. The Global Severity Index (GSI) is a measure of overall psychological distress and is calculated by summing up all nine subscales. Urbán and colleagues [24 (link)] proposed a bifactor model that supports reporting the nine subscales in addition to the rather sound GSI as outcome measures. In this study, Cronbach’s alpha of the GSI was .97 and .96 at baseline and follow-up, respectively.
Full text: Click here
Publication 2019
Anxiety Hypersensitivity Mental Disorders Obsessive-Compulsive Disorder Psychological Distress Psychometrics Sound Syndrome
To collect ASD candidate genes for the first release of AutDB, we performed a comprehensive search of all articles in the PubMed database maintained at NCBI (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed). The search terms included ‘gene’ AND (‘autism’ OR ‘autistic’) restricted to the titles and abstracts of the publications for retrieval. Furthermore, candidate genes listed in review articles on molecular genetics of ASD, along with cross-references therein, were mapped and added (if new) to our candidate gene list from PubMed searches to compile the most exhaustive gene set. After the first release, starting from June 2006, a daily semi automated search of the PubMed with the same keywords is implemented to maintain an up-to-date resource of all candidate genes linked to ASD. Additionally, relevant journal articles in the fields of genetics, neurobiology, and psychiatry are screened on a regular basis to enrich the resource.
To select the primary reference for a candidate gene, the first positive report linking the gene to (ASD) was searched in PubMed. However, to select the primary reference for a ‘Syndromic autism’ gene where a large number of reports are published connecting the syndrome to autism, we adopted the following steps: First, google scholar is used with the criteria [(autism OR autistic) AND ‘syndrome name’ AND ‘gene name’] to search for the most highly cited reports. Next, a primary reference is selected among these highly cited reports by reading the article (see Supplementary Table 1).
Publication 2008
Autistic Disorder Genes Syndrome
As with the Poisson- and Bernoulli-based prospective space–time scan statistics [27 ], the space–time permutation scan statistic utilizes thousands or millions of overlapping cylinders to define the scanning window, each being a possible candidate for an outbreak. The circular base represents the geographical area of the potential outbreak. A typical approach is to first iterate over a finite number geographical grid points and then gradually increase the circle radius from zero to some maximum value defined by the user, iterating over the zip codes in the order in which they enter the circle. In this way, both small and large circles are considered, all of which overlap with many other circles. The height of the cylinder represents the number of days, with the requirement that the last day is always included together with a variable number of preceding days, up to some maximum defined by the user. For example, we may consider all cylinders with a height of 1, 2, 3, 4, 5, 6, or 7 d. For each center and radius of the circular cylinder base, the method iterates over all possible temporal cylinder lengths. This means that we will evaluate cylinders that are geographically large and temporally short, forming a flat disk, those that are geographically small and temporally long, forming a pole, and every other combination in between.
What is new with the space–time permutation scan statistic is the probability model. Since we do not have population-at-risk data, the expected must be calculated using only the cases. Suppose we have daily case counts for zip-code areas, where czd is the observed number of cases in zip-code area z during day d. The total number of observed cases (C) is

For each zip code and day, we calculate the expected number of cases μzd conditioning on the observed marginals:

In words, this is the proportion of all cases that occurred in zip-code area z times the total number of cases during day d. The expected number of cases μA in a particular cylinder A is the summation of these expectations over all the zip-code-days within that cylinder:

The underlying assumption when calculating these expected numbers is that the probability of a case being in zip-code area z, given that it was observed on day d, is the same for all days d.
Let cA be the observed number of cases in the cylinder. Conditioned on the marginals, and when there is no space–time interaction, cA is distributed according to the hypergeometric distribution with mean μA and probability function

When both ΣzεAczd and ΣdεAczd are small compared to C, cA is approximately Poisson distributed with mean μA [37 ]. Based on this approximation, we use the Poisson generalized likelihood ratio (GLR) as a measure of the evidence that cylinder A contains an outbreak:

In words, this is the observed divided by the expected to the power of the observed inside the cylinder, multiplied by the observed divided by the expected to the power of the observed outside the cylinder. Among the many cylinders evaluated, the one with the maximum GLR constitutes the space–time cluster of cases that is least likely to be a chance occurrence and, hence, is the primary candidate for a true outbreak. One reason for using the Poisson approximation is that it is much easier to work with this distribution than the hypergeometric when adjusting for space by day-of-week interaction (see below), as the sum of Poisson distributions is still a Poisson distribution.
Since we are evaluating a huge number of outbreak locations, sizes, and time lengths, there is serious multiple testing that we need to adjust for. Since we do not have population-at-risk data, this cannot be done in any of the usual ways for scan statistics. Instead, it is done by creating a large number of random permutations of the spatial and temporal attributes of each case in the dataset. That is, we shuffle the dates/times and assign them to the original set of case locations, ensuring that both the spatial and temporal marginals are unchanged. After that, the most likely cluster is calculated for each simulated dataset in exactly the same way as for the real data. Statistical significance is evaluated using Monte Carlo hypothesis testing [38 ]. If, for example, the maximum GLR is calculated from 999 simulated datasets, and the maximum GLR for the real data is higher than the 50th highest, then that cluster is statistically significant at the 0.05 level. In general terms, the p-value is p = R/(S + 1) where R is the rank of the maximum GLR from the real dataset and S is the number of simulated datasets [38 ]. In addition to p-values, we also report null occurrence rates [8 (link)], such as once every 45 d or once every 23 mo. The null occurrence rate is the expected time between seeing an outbreak signal with an equal or higher GLR assuming that the null hypothesis is true. For daily analyses, it is defined as once every 1/p d. For example, under the null hypothesis we would at the 0.05 level on average expect one false alarm every 20 d for each syndrome under surveillance.
Because of the Monte Carlo hypothesis testing, the method is computer intensive. To facilitate the use of the methods by local, state, and federal health departments, the space–time permutation scan statistic has been implemented as a feature in the free and public domain SaTScan software [36 ].
Full text: Click here
Publication 2005
MLL protein, human Population at Risk Public Domain Radionuclide Imaging Radius Syndrome

Most recents protocols related to «Syndrome»

The proportion of patients with COD was not significantly different for male (45.4%) and female (52.0%) patients (p = 0.139). The prevalence rates for the types of co-occurring psychiatric diagnoses are shown in Table 2. Among patients with COD, anxiety (22.9%) and mood disorders (17.3%) were the two most common psychiatric disorders. About one in five had more than one COD (21.4%), with a higher prevalence rate of multiple CODs among females (30.3%) than males (18.0%). Having anxiety disorders were significantly more prevalent among females (30.3%) than males (19.8%).

Prevalence of co-occurring psychiatric disorders

Total(N = 611)Females(N = 175)Males(N = 434)Females versus malesref
N%N%N%ORp-value
Without COD32252.78448.023754.6
With COD28947.39152.019745.41.300.139
Psychiatric diagnoses1
- Anxiety disorders F40-4914022.95330.38619.81.760.005
- Mood disorders F30-3910617.33620.67016.11.350.191
- ADHD F90.0-F90.97912.92112.05813.40.880.650
- Personality disorders F60-697011.52715.4439.91.660.053
- Multiple CODs13121.453*30.37818.01.98< 0.001

1 Other psychiatric diagnoses (n = 17) included Schizophrenia, F20-F29 (n = 8); Behavioral syndromes associated with physiological disorders and physical factors (n = 16); Mental retardation, F70-F79 (n = 6); Pervasive and specific developmental disorders, F80-89 (n = 16); Behavioral disorders, F91-F98 (n = 8)

Full text: Click here
Publication 2023
Anxiety Disorders Behavior Disorders Cods Developmental Disabilities Diagnosis, Psychiatric Disorder, Attention Deficit-Hyperactivity Females Intellectual Disability Males Mental Disorders Mood Mood Disorders Patients Personality Disorders Physical Examination physiology Schizophrenia Syndrome Woman
In this retrospective study, all patients with angina pectoris and who underwent exercise ECG tests were screened between August 2017 and September 2018. The Institutional Review Board of Mackay Memorial Hospital approved this study protocol (IRB No. 17MMHIS004e), which waived the requirement for informed consent in this retrospective study. The treating physicians decided on the need to perform exercise ECG tests after excluding ECG abnormalities, including LBBB, paced rhythm, Wolff–Parkinson–White syndrome, ≥ 0.1-mV ST-segment depression on resting ECG, or who are being treated with digitalis. The use of exercise ECG test was indicated by treating physicians and re-confirmed by other two cardiologists. Patients with positive exercise ECG were suggested to undergo coronary imaging, including coronary angiography or computed tomography. Based on the coronary stenoses severity, patients with positive exercise ECG were divided into three groups: normal, < 50%, and ≥ 50% stenoses. According to 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes [7 (link)], the negative predictive value of exercise ECG was higher than positive predictive value. The likelihood of CAD was less than 15% if negative exercise ECG. Therefore, patients with negative exercise ECG were defined as a relative health group. Compared with patients with negative exercise ECG, analysis models were designed (model 1, positive exercise ECG; model 2, < 50% and ≥ 50% stenoses; and model 3, normal, < 50%, and ≥ 50% stenoses).
Full text: Click here
Publication 2023
Angina Pectoris Cardiologists Congenital Abnormality Coronary Angiography Coronary Stenosis Diagnosis Digitalis Exercise Tests Heart Left Bundle-Branch Block Patients Physicians Stenosis Syndrome Wolff-Parkinson-White Syndrome X-Ray Computed Tomography
Patient data from the Paris cohort and the BIODEGMAR cohort was examined using two stratification criteria: (i) according to clinical syndrome (cognitively unimpaired [CU], MCI, or dementia) and CSF amyloid status (Aβ−/Aβ+, as defined by Lumipulse CSF Aβ1-42/40, Supplementary Table 3), resulting in six groups: CU Aβ−, CU Aβ+, MCI Aβ−, MCI Aβ+, dementia Aβ− and dementia Aβ+ (clinical diagnosis included in each group are available in Supplementary Tables 1 and 2); (ii) based on the Aβ (A) and tau (T) status defined using CSF Aβ1–42/40 and p-tau181, respectively (Lumipulse®) into A−T−, A+T− and A+T+ (the A−T+ group considered suspected non-AD pathology [SNAP] was not included in the statistical analysis, but is depicted in the boxplots). The clinical diagnoses included in each group are available in Supplementary Tables 5 and 6). Additionally, CSF p-tau235 levels across clinical diagnostic groups for both cohorts are available in Supplementary Figure 1.
Full text: Click here
Publication 2023
APP protein, human Diagnosis Patients Presenile Dementia Syndrome
We performed a focused literature search and consulted with a working group of experienced clinicians, researchers, and patient partners to collate a list of frailty-related terms. This approach was adapted from Urquhart et al.’s development of a rule to identify frailty in administrative health databases [25 (link)]. The aim was to construct a list of terms or phrases that would commonly be used by providers to describe patients living with frailty.
The focused literature review involved an initial scan of PubMed using combinations of the following terms: “frail elderly”, “frailty”, “identification”, “definition”, “database”, and “health data”. We were particularly interested in studies that have used key-term searching to identify frailty in the free text of other healthcare datasets. We considered a variety of study types, including systematic reviews and other evidence syntheses, clinical guidelines, retrospective studies of healthcare or administrative databases, and studies that have developed or validated frailty assessment tools. Search results were supplemented by articles recommended by the research team and a hand search of reference lists of selected articles.
Relevant findings from the literature search were summarized. From each included study, we extracted terms related to the identification or assessment of frailty, including but not limited to signs and symptoms, comorbidities, disabilities, and related clinical syndromes.
To ensure the content validity of our selection, the preliminary list of frailty-related terms was then shared for feedback with a working group of clinicians (n = 4), researchers (n = 4) and a patient partner (n = 1) who are knowledgeable about LTC, primary care and frailty, each bringing diverse perspectives on these topics (see corresponding section in Supplemental Methods). Through iterative discussions and revisions, a version of the list of frailty terms was finalized for a key-term search of the eConsult text. The list was organized by grouping terms into overarching topic categories.
Full text: Click here
Publication 2023
Anabolism Disabled Persons Frail Elderly Patients Primary Health Care Radionuclide Imaging Syndrome
We collected basic information, including age, gender, education, onset, and duration of MDD, and married status through a self-designed questionnaire. All participants were independently interviewed face-to-face by two trained psychiatrists via the SCID. Two psychiatrists independently assessed each participant’s depression, anxiety, and psychotic symptoms by the HAMD, Hamilton Anxiety Scale (HAMA), and the positive subscale of Positive and Negative Syndrome Subscale (PANSS), respectively. HAMD score ranges from 0-52, with a cutoff point of 24 being used to determine severe depression (28 (link)). HAMA consists of 14 items, measuring psychological and somatic anxiety symptoms (29 (link)). It applied the 5-Likert scale, with a total score ranging from 0-56. The PANSS positive subscale assesses seven positive symptoms (30 (link)). The PANSS-positive subscale score ranges from 7-49. Higher scores on the HAMA, HAMD, and PANSS indicate more severe symptoms. These three scales have been validated and widely used in the Chinese population (31 (link)–33 (link)). According to previous studies (34 (link), 35 (link)), HAMA score >20 and PANSS positive subscale score >14 indicate significant anxiety and psychotic symptoms, respectively. The correlation coefficients between the two psychiatrists’ scores on all three scales were higher than 0.8.
We assessed SA through face-face interviews. All participants were asked the question: “In your lifetime, did you ever try to kill yourself?”. This single item has been validated and used widely in previous epidemiological studies for the detection of SA (36 (link), 37 (link)). Those who answered “yes” were considered to have lifetime SA. We further asked them about the timing and frequency of SA. We contacted the family members of the participants for the details of SA when patients were unable to provide definitive information.
Full text: Click here
Publication 2023
Anxiety Chinese Face Family Member Gender Medically Unexplained Symptoms Mental Disorders Patients Psychiatrist SCID Mice Syndrome

Top products related to «Syndrome»

Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States, Austria, Japan, Belgium, United Kingdom, Cameroon, China, Denmark, Canada, Israel, New Caledonia, Germany, Poland, India, France, Ireland, Australia
SAS 9.4 is an integrated software suite for advanced analytics, data management, and business intelligence. It provides a comprehensive platform for data analysis, modeling, and reporting. SAS 9.4 offers a wide range of capabilities, including data manipulation, statistical analysis, predictive modeling, and visual data exploration.
Sourced in United States, United Kingdom, Japan, Austria, Germany, Denmark, Czechia, Belgium, Sweden, New Zealand, Spain
SPSS version 25 is a statistical software package developed by IBM. It is designed to analyze and manage data, providing users with a wide range of statistical analysis tools and techniques. The software is widely used in various fields, including academia, research, and business, for data processing, analysis, and reporting purposes.
Sourced in United States, Japan, United Kingdom, Germany, Belgium, Austria, China, Spain, Ireland
SPSS version 24 is a statistical software package developed by IBM. It provides a comprehensive set of tools for data analysis, including techniques for descriptive statistics, regression analysis, and predictive modeling. The software is designed to help users interpret data, identify trends, and make informed decisions based on statistical insights.
Sourced in United States, Japan, United Kingdom, Germany, Belgium, Austria, Italy, Poland, India, Canada, Switzerland, Spain, China, Sweden, Brazil, Australia, Hong Kong
SPSS Statistics is a software package used for interactive or batched statistical analysis. It provides data access and management, analytical reporting, graphics, and modeling capabilities.
Sourced in United States, China, Germany, United Kingdom, Hong Kong, Canada, Switzerland, Australia, France, Japan, Italy, Sweden, Denmark, Cameroon, Spain, India, Netherlands, Belgium, Norway, Singapore, Brazil
The HiSeq 2000 is a high-throughput DNA sequencing system designed by Illumina. It utilizes sequencing-by-synthesis technology to generate large volumes of sequence data. The HiSeq 2000 is capable of producing up to 600 gigabases of sequence data per run.
Sourced in United States, China, Germany, United Kingdom, Spain, Australia, Italy, Canada, Switzerland, France, Cameroon, India, Japan, Belgium, Ireland, Israel, Norway, Finland, Netherlands, Sweden, Singapore, Portugal, Poland, Czechia, Hong Kong, Brazil
The MiSeq platform is a benchtop sequencing system designed for targeted, amplicon-based sequencing applications. The system uses Illumina's proprietary sequencing-by-synthesis technology to generate sequencing data. The MiSeq platform is capable of generating up to 15 gigabases of sequencing data per run.
Sourced in Germany, United States, Spain, United Kingdom, Japan, Netherlands, France, China, Canada, Italy, Australia, Switzerland, India, Brazil, Norway
The QIAamp DNA Blood Mini Kit is a laboratory equipment designed for the extraction and purification of genomic DNA from small volumes of whole blood, buffy coat, plasma, or serum samples. It utilizes a silica-based membrane technology to efficiently capture and wash DNA, while removing contaminants and inhibitors.
Sourced in United States, Denmark, Austria, United Kingdom, Japan, Canada
Stata version 14 is a software package for data analysis, statistical modeling, and graphics. It provides a comprehensive set of tools for data management, analysis, and reporting. Stata version 14 includes a wide range of statistical techniques, including linear regression, logistic regression, time series analysis, and more. The software is designed to be user-friendly and offers a variety of data visualization options.

More about "Syndrome"

Syndrome is a term used to describe a collection of signs, symptoms, and characteristics that collectively define a particular health condition or disease.
These syndromes can involve a wide range of bodily systems and functions, and may be caused by genetic, environmental, or other factors.
Understanding syndromes is crucial for accurate diagnosis, effective treatment, and advancing medical research.
One of the key tools for syndrome research is statistical analysis software (SAS) and SPSS.
SAS version 9.4 and SPSS version 25 are commonly used for data analysis, while SPSS Statistics provides a comprehensive set of tools for data management, analysis, and visualization.
Similarly, sequencing platforms like the HiSeq 2000 and MiSeq platform are used to generate genetic data that can provide insights into the underlying causes of syndromes.
Furthermore, tools like the QIAamp DNA Blood Mini Kit are used to extract and purify DNA samples, which are then analyzed using statistical software like Stata version 14.
These combined methodologies help researchers identify patterns, risk factors, and potential treatments for various syndromes.
PubCompare.ai's AI-driven protocol comparisons can further enhance the research process by identifying the best methodologies from literature, pre-prints, and patents.
This can help improve reproducibility and accuracy, simplifying the research process and achieving more relibale results.
By leveraging these advanced tools and techniques, researchers can make significant strides in understanding and managing syndromes, leading to improved patient outcomes and advancements in the field of medicine.